136 related articles for article (PubMed ID: 1544384)
21. Derivation of mixed phenotype cell lines with ras-myc- and raf-myc-containing retroviral vectors after infection of murine long-term bone marrow cultures.
Spoor E; Ziegler SF; Overell RW; deVries P; Williams DE
Exp Hematol; 1991 Aug; 19(7):664-8. PubMed ID: 1716589
[TBL] [Abstract][Full Text] [Related]
22. ABL-MYC retroviral infection elicits bone marrow plasma cell tumors in Bcl-X(L) transgenic mice.
Linden M; Kirchhof N; Kvitrud M; Van Ness B
Leuk Res; 2005 Apr; 29(4):435-44. PubMed ID: 15725478
[TBL] [Abstract][Full Text] [Related]
23. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow-derived cells are responsible for the development of autoimmune arthritis in human T cell leukemia virus type I-transgenic mice and those of normal mice can suppress the disease.
Saijo S; Kotani M; Habu K; Ishitsuka C; Yamamoto H; Sekiguchi T; Iwakura Y
J Immunol; 1999 Nov; 163(10):5700-7. PubMed ID: 10553101
[TBL] [Abstract][Full Text] [Related]
25. Expression of beta-galactosidase under the control of the human c-myc promoter in transgenic mice is inhibited by mithramycin.
Jones DE; Cui DM; Miller DM
Oncogene; 1995 Jun; 10(12):2323-30. PubMed ID: 7784080
[TBL] [Abstract][Full Text] [Related]
26. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.
Zörnig M; Busch G; Beneke R; Gulbins E; Lang F; Ma A; Korsmeyer S; Möröy T
Oncogene; 1995 Nov; 11(10):2165-74. PubMed ID: 7478538
[TBL] [Abstract][Full Text] [Related]
27. Elevated c-myc messenger RNA in multiple myeloma cell lines.
Fourney R; Palmer M; Ng A; Dietrich K; Belch A; Paterson M; Brox L
Dis Markers; 1990; 8(3):117-24. PubMed ID: 1980237
[TBL] [Abstract][Full Text] [Related]
28. Possible collaboration between c-fos and c-myc proto-oncogene products in in vivo lymphomagenesis.
Takao S; Sakai N; Aizawa S; Tokuhisa T
Kobe J Med Sci; 1991 Oct; 37(4-5):227-43. PubMed ID: 1724994
[TBL] [Abstract][Full Text] [Related]
29. Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.
Liu P; Terradillos O; Renard CA; Feldmann G; Buendia MA; Bernuau D
Hepatology; 1997 Apr; 25(4):874-83. PubMed ID: 9096591
[TBL] [Abstract][Full Text] [Related]
30. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.
Cleveland JL; Jansen HW; Bister K; Fredrickson TN; Morse HC; Ihle JN; Rapp UR
J Cell Biochem; 1986; 30(3):195-218. PubMed ID: 3084503
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow transplantation with T-cell-depleted grafts. II. Reconstitution of immunohemopoietic functions in lethally irradiated mice transplanted with unseparated or T-cell-depleted bone marrow grafts disparate at minor histocompatibility antigens.
Leshem B; Tsuberi BZ; Lebendiker Z; Anafi-Ayalon M; Shalit M; Weiss L; Slavin S; Kedar E
Transplantation; 1987 Jun; 43(6):814-7. PubMed ID: 2954282
[TBL] [Abstract][Full Text] [Related]
32. Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate.
James RI; May C; Vagt MD; Studebaker R; McIvor RS
Exp Hematol; 1997 Nov; 25(12):1286-95. PubMed ID: 9357973
[TBL] [Abstract][Full Text] [Related]
33. Mesenteric hemopoietic colonies: occurrence in BALB/c mice after transplantation of syngeneic normal or leukemic hemopoietic cells.
Umar MH; van Griensven LJ
Exp Hematol; 1977; 5(4):281-90. PubMed ID: 330182
[TBL] [Abstract][Full Text] [Related]
34. Transgenic expression of VpreB-3 under the control of the immunoglobulin heavy chain enhancer and SV40 promoter.
Hagiwara S
Kobe J Med Sci; 1996 Feb; 42(1):43-59. PubMed ID: 8984229
[TBL] [Abstract][Full Text] [Related]
35. Both myeloproliferative disease and leukemia are induced by transplantation of bone marrow cells expressing v-myc.
Bonham L; MacKenzie K; Wood S; Rowe PB; Symonds G
Oncogene; 1992 Nov; 7(11):2219-29. PubMed ID: 1437146
[TBL] [Abstract][Full Text] [Related]
36. Differential killing of murine B-cell leukemia (BCL1) by photosensitization with merocyanine 540: implications for autologous bone marrow transplantation.
Mumcuoglu M; Weiss L; Spivak J; Slavin S
Bone Marrow Transplant; 1989 Mar; 4(2):143-6. PubMed ID: 2650782
[TBL] [Abstract][Full Text] [Related]
37. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
38. Treatment of BCL1 leukemia by transplantation of low density fractions of allogeneic bone marrow and spleen cells.
Palathumpat V; Holm B; Dejbakhsh-Jones S; Strober S
J Immunol; 1992 May; 148(10):3319-26. PubMed ID: 1578152
[TBL] [Abstract][Full Text] [Related]
39. Ex vivo culture rescues hematopoietic stem cells with long-term repopulating capacity following harvest from lethally irradiated mice.
Chute JP; Fung J; Muramoto G; Erwin R
Exp Hematol; 2004 Mar; 32(3):308-17. PubMed ID: 15003317
[TBL] [Abstract][Full Text] [Related]
40. Cognate T cell help for CD40-deficient B cells induces c-myc RNA expression, but DNA synthesis requires an additional signal through surface Ig.
Schrader CE; Stavnezer J; Kikutani H; Parker DC
J Immunol; 1997 Jan; 158(1):153-62. PubMed ID: 8977186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
